 Home > Active Ingredient News > Antitumor Therapy > The European Union approved Tukysa for the treatment of HER2-positive localized advanced or metastasis breast cancer

The European Union approved Tukysa for the treatment of HER2-positive localized advanced or metastasis breast cancer

 Last Update: 2021-02-25
 Source: Internet
 Author: User

Tags

rho kinase inhibitor

breast cancer metastasis lung

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Seagen International (Seagen) recently announced that the European Commission (EC) has approved the sale of its HER2 tyrosine kinase inhibitor (TKI) Tukysa for the treatment of HER2-positive localized advanced or metastasis breast cancer.
EC has approved Tukysa (tucatinib) combined with tukysa monoantigen and capedabin for the treatment of adult patients with advanced HER2-positive breast cancer who have received at least two previous treatments against HER2.
in the HER2CLIMB trial at Tukysa in Seagen, TKI and cratur bead monoantigen and carpedabin used to reduce the risk of disease progress in patients by 46%.
survival of patients in the Tukysa combined treatment group was also improved, with a 34 percent reduction in the risk of death. clay Siegall, chief executive of
Seagen, said: "Tukysa combination therapy is a milestone for patients with or without HER2-positive metastasis breast cancer with or without brain metastasis and can extend the overall survival of both patients.
we are pleased that Tukysa has now been approved in Europe and look forward to further cooperation with various countries to ensure that patients can use it in a timely manner."

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.